Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Total Current Liabilities (2021 - 2025)

Roivant Sciences' Total Current Liabilities history spans 5 years, with the latest figure at $152.0 million for Q4 2025.

  • For Q4 2025, Total Current Liabilities fell 53.9% year-over-year to $152.0 million; the TTM value through Dec 2025 reached $152.0 million, down 53.9%, while the annual FY2025 figure was $149.4 million, 43.99% down from the prior year.
  • Total Current Liabilities reached $152.0 million in Q4 2025 per ROIV's latest filing, up from $133.9 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $556.2 million in Q3 2024 to a low of $113.9 million in Q2 2025.
  • Average Total Current Liabilities over 5 years is $244.6 million, with a median of $237.5 million recorded in 2022.
  • Peak YoY movement for Total Current Liabilities: soared 109.47% in 2024, then plummeted 75.94% in 2025.
  • A 5-year view of Total Current Liabilities shows it stood at $160.7 million in 2021, then soared by 51.98% to $244.3 million in 2022, then rose by 27.36% to $311.1 million in 2023, then increased by 5.96% to $329.6 million in 2024, then plummeted by 53.9% to $152.0 million in 2025.
  • Per Business Quant, the three most recent readings for ROIV's Total Current Liabilities are $152.0 million (Q4 2025), $133.9 million (Q3 2025), and $113.9 million (Q2 2025).